Activin A Protein: From Key Physiological Regulator to Novel Therapeutic Target
Activin A, a key member of the TGF-β superfamily, is a dimeric protein formed by two βA subunits linked via disulfide bonds. This critical signaling molecule plays a central role in physiological processes such as embryonic development, tissue repair, and immune regulation, but its dysregulation has also become a pivotal factor in the pathogenesis of various diseases.
- Recent Advances
- Product Information
Overview: The Dual Role of Pleiotropic Cytokines
Activin A, an important member of the transforming growth factor-β superfamily, is a dimeric protein formed by two βA subunits connected via disulfide bonds. This crucial signaling molecule plays a central role in various physiological processes including embryonic development, tissue repair, and immune regulation, while its dysregulation has become a key factor in the pathogenesis of multiple diseases.
Core Biological Functions
Reproductive System Regulation
Promotes pituitary FSH synthesis and secretion
Regulates germ cell development and maturation
Participates in menstrual cycle regulation
Tissue Repair and Regeneration
Mediates wound healing processes
Regulates stem cell differentiation
Involved in skeletal muscle regeneration
Immune Modulation
Regulates macrophage polarization
Affects lymphocyte function
Participates in inflammatory response regulation
Disease Association Mechanisms
Fibrotic Diseases
Pulmonary fibrosis: Promotes fibroblast activation, drives excessive ECM deposition
Liver fibrosis: Activates hepatic stellate cells, accelerates collagen production
Renal fibrosis: Promotes renal tubular epithelial cell mesenchymal transition
Tumor Progression
Promotes epithelial-mesenchymal transition
Enhances tumor cell invasiveness
Induces angiogenesis
Creates immunosuppressive microenvironment
Metabolic Diseases
Involved in insulin resistance
Regulates adipocyte differentiation
Affects energy metabolism balance
Muscle Atrophy-related Disorders
Cancer cachexia
Age-related sarcopenia
Neuromuscular diseases
Clinical Translation Prospects
Diagnostic Biomarkers
Serum Activin A levels as:
Fibrotic disease progression indicator
Tumor treatment efficacy monitoring marker
Inflammatory disease activity assessment
Therapeutic Target Development
Antagonist Strategies
Soluble receptor traps (ACE-031/536)
Follistatin analogs
Specific monoclonal antibodies
Clinical Research Progress
Myelodysplastic syndrome treatment
Muscle atrophy disorder intervention
Fibrotic disease therapy exploration
Research Tools and Reagents
Recombinant Activin A protein
Specific detection antibodies
Signaling pathway research kits
Animal disease models
Prospects and Challenges
With deepening understanding of Activin A signaling pathways, targeted therapies against this pathway offer new hope for various refractory diseases. Future research will focus on:
Tissue-specific regulation strategies
Combination therapy development
Biomarker validation system establishment
Long-term safety evaluation












